Knight Therapeutics Inc. announced that Jonathan Ross Goodman has resigned from the company's Board of Directors, effective . Mr. Goodman has been a Director since June 2013. Samira Sakhia will replace Mr. Goodman as chair of the Audit Committee.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.87 CAD | 0.00% | -2.17% | +13.10% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.10% | 434M | |
+18.88% | 81.33B | |
+14.11% | 9.14B | |
-15.14% | 4.89B | |
+46.88% | 4.61B | |
+15.70% | 4.36B | |
+7.93% | 2.26B | |
-27.88% | 2.15B | |
+15.73% | 2.1B | |
-43.02% | 1.78B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Inc. Announces Board Changes